Cite
Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.
MLA
Zou, Jun, et al. “Overexpression of TPX2 Is Associated with Progression and Prognosis of Prostate Cancer.” Oncology Letters, vol. 16, no. 3, Sept. 2018, pp. 2823–32. EBSCOhost, https://doi.org/10.3892/ol.2018.9016.
APA
Zou, J., Huang, R.-Y., Jiang, F.-Nen., ChEN, D.-X., Wang, C., Han, Z.-D., Liang, Y.-X., & Zhong, W.-D. (2018). Overexpression of TPX2 is associated with progression and prognosis of prostate cancer. Oncology Letters, 16(3), 2823–2832. https://doi.org/10.3892/ol.2018.9016
Chicago
Zou, Jun, Rui-Yan Huang, Fu-NeNg Jiang, De-Xiong ChEN, Cong Wang, Zhao-Dong Han, Yu-Xiang Liang, and Wei-De Zhong. 2018. “Overexpression of TPX2 Is Associated with Progression and Prognosis of Prostate Cancer.” Oncology Letters 16 (3): 2823–32. doi:10.3892/ol.2018.9016.